SENISCA is an award-winning biotech spinout from the University of Exeter (founded 2020) that develops RNA-based senotherapeutics designed to reverse cellular senescence (ageing). By targeting dysregulated RNA splicing to “rejuvenate” cells, SENISCA aims to treat chronic, age-related diseases affecting the lungs, eyes, brain, and joints.

